+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Sinusitis Drugs Market 2021-2025- Product Image

Global Sinusitis Drugs Market 2021-2025

  • ID: 5304738
  • Report
  • February 2021
  • Region: Global
  • 120 pages
  • TechNavio

FEATURED COMPANIES

  • AbbVie Inc.
  • Bayer AG
  • GlaxoSmithKline Plc
  • Hikma Pharmaceuticals Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Sinusitis Drugs Market 2021-2025

The publisher has been monitoring the sinusitis drugs market and it is poised to grow by $ 466.44 mn during 2021-2025, progressing at a CAGR of 4% during the forecast period. The report on sinusitis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of sinusitis, growing awareness among people about sinusitis treatment and increasing mergers and acquisitions. In addition, rising prevalence of sinusitis is anticipated to boost the growth of the market as well.

The sinusitis drugs market analysis includes product segment and geographical landscapes.

The sinusitis drugs market is segmented as below:

By Product
  • Steroid nasal sprays
  • Antibiotics
  • Decongestants
  • Other drugs
By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies advent of biologics as one of the prime reasons driving the sinusitis drugs market growth during the next few years. Also, increasing investments in R&D by major players and technological advances will lead to sizable demand in the market.

The report on sinusitis drugs market covers the following areas:
  • Sinusitis drugs market sizing
  • Sinusitis drugs market forecast
  • Sinusitis drugs market industry analysis
The publisher robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sinusitis drugs market vendors that include AbbVie Inc., Bayer AG, GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Johnson & Johnson, Merck & Co. Inc., Neopharma Corp., Pfizer Inc., Sanofi SA, and Sun Pharmaceutical Industries Ltd. Also, the sinusitis drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Bayer AG
  • GlaxoSmithKline Plc
  • Hikma Pharmaceuticals Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Steroid nasal sprays - Market size and forecast 2020-2025
  • Antibiotics - Market size and forecast 2020-2025
  • Decongestants - Market size and forecast 2020-2025
  • Other drugs - Market size and forecast 2020-2025
  • Market opportunity by Product
Customer Landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Vendor landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • Bayer AG
  • GlaxoSmithKline Plc
  • Hikma Pharmaceuticals Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Neopharma Corp.
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Product - Market share 2020-2025 (%)
  • Comparison by Product
  • Steroid nasal sprays - Market size and forecast 2020-2025 ($ million)
  • Steroid nasal sprays - Year-over-year growth 2020-2025 (%)
  • Antibiotics - Market size and forecast 2020-2025 ($ million)
  • Antibiotics - Year-over-year growth 2020-2025 (%)
  • Decongestants - Market size and forecast 2020-2025 ($ million)
  • Decongestants - Year-over-year growth 2020-2025 (%)
  • Other drugs - Market size and forecast 2020-2025 ($ million)
  • Other drugs - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Product
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Business segments
  • AbbVie Inc. - Key offerings
  • AbbVie Inc. - Key customers
  • AbbVie Inc. - Segment focus
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key offerings
  • Bayer AG - Key customers
  • Bayer AG - Segment focus
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Key customers
  • GlaxoSmithKline Plc - Segment focus
  • Hikma Pharmaceuticals Plc - Overview
  • Hikma Pharmaceuticals Plc - Business segments
  • Hikma Pharmaceuticals Plc - Key offerings
  • Hikma Pharmaceuticals Plc - Key customers
  • Hikma Pharmaceuticals Plc - Segment focus
  • Johnson & Johnson - Overview
  • Johnson & Johnson - Business segments
  • Johnson & Johnson - Key offerings
  • Johnson & Johnson - Key customers
  • Johnson & Johnson - Segment focus
  • Merck & Co. Inc. - Overview
  • Merck & Co. Inc. - Business segments
  • Merck & Co. Inc. - Key offerings
  • Merck & Co. Inc. - Key customers
  • Merck & Co. Inc. - Segment focus
  • Neopharma Corp. - Overview
  • Neopharma Corp. - Product and service
  • Neopharma Corp. - Key offerings
  • Neopharma Corp. - Key customers
  • Neopharma Corp. - Segment focus
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Key customers
  • Pfizer Inc. - Segment focus
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key offerings
  • Sanofi SA - Key customers
  • Sanofi SA - Segment focus
  • Sun Pharmaceutical Industries Ltd. - Overview
  • Sun Pharmaceutical Industries Ltd. - Business segments
  • Sun Pharmaceutical Industries Ltd. - Key offerings
  • Sun Pharmaceutical Industries Ltd. - Key customers
  • Sun Pharmaceutical Industries Ltd. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Bayer AG
  • GlaxoSmithKline Plc
  • Hikma Pharmaceuticals Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
The publisher recognizes the following companies as the key players in the global sinusitis drugs market: AbbVie Inc., Bayer AG, GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Johnson & Johnson, Merck & Co. Inc., Neopharma Corp., Pfizer Inc., Sanofi SA, and Sun Pharmaceutical Industries Ltd.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is advent of biologics.'

According to the report, one of the major drivers for this market is the rising prevalence of sinusitis.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
  • AbbVie Inc.
  • Bayer AG
  • GlaxoSmithKline Plc
  • Hikma Pharmaceuticals Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Neopharma Corp.
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll